HNSBF Stock Latest News
Company AnnouncementsHansa Biopharma CEO to Spotlight Nordic Deal-Making at BioStock Life Science Summit4d ago
Company AnnouncementsHansa Biopharma sets November date for Q3 2026 results and pipeline update6d ago
Company AnnouncementsHansa Biopharma’s Idefirix posts strong one-year outcomes in key post-authorization kidney transplant study1w ago- Company AnnouncementsHansa Biopharma’s Idefirix PAES Study Earns High-Impact Spotlight at ASN Kidney Week2w ago
Company AnnouncementsHansa Biopharma Files IND with FDA for Novel GBS Therapy HNSA-54872w ago
Company AnnouncementsHansa Biopharma leadership to highlight kidney transplant focus at U.S. virtual forum3w agoCompany AnnouncementsHansa Biopharma Taps Cradle’s AI Platform to Speed Autoimmune Drug Discovery1M ago
- Company AnnouncementsHansa Biopharma Adds Commercial and Financial Heavyweights to Board1M ago
- Company AnnouncementsHansa Biopharma Adds New Directors and Adopts Long-Term RSU Program at Extraordinary Meeting1M ago
Company AnnouncementsHansa Biopharma Joins Global Expansion Panel at LSX Congress USA1M ago- Company AnnouncementsHansa Biopharma CEO to Present at Pareto Securities’ 2026 Healthcare Conference2M ago
Company AnnouncementsHansa Biopharma Calls Extraordinary Meeting to Reshape Board and Governance2M agoCompany AnnouncementsHansa Biopharma Prepares for Potential U.S. ADS Listing and Global Share Offering2M ago
Company AnnouncementsHansa Biopharma Marks First Commercial Idefirix Kidney Transplant in Australia2M ago
- Company AnnouncementsHansa Biopharma Bets Big On U.S. Kidney Launch3M ago
- Company AnnouncementsHansa Biopharma bolsters finances with €115m Idefirix deal as clinical data strengthen transplant outlook3M ago
- Company AnnouncementsHansa Biopharma sets Q2 2026 results release and investor call3M ago
Company AnnouncementsHansa Biopharma to Highlight Kidney Desensitization Technology at Wedbush PacGrow Renal Summit4M ago